Aspiriant LLC’s HNI Corp HNI Stock Holding History

Aspiriant LLC’s Portfolio HNI Stock Details HNI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-7,781	Closed	-$289K	–	249
2018 Q2	$289K	Buy	+7,781	New	+$284K	0.02%	204
2014 Q1	–	Sell	-40,590	Closed	-$1.58M	–	83
2013 Q4	$1.58M	Buy	+40,590	New	+$1.54M	0.25%	32

Other funds holding HNI

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

DRZID

DePrince Race & Zollo Inc (DRZ) Winter Park, Florida $5.29B AUM 20.14% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Aspiriant LLC's HNI Position: Q3 2018 in Review

Aspiriant LLC sold out of HNI Corp (HNI) in Q3 2018, closing a stake of 7,781 shares — an estimated $289K sold.

Aspiriant LLC first reported a position in HNI in Q4 2013 and held it in 2 quarters. The position peaked at $1.58M in Q4 2013. 178 funds tracked by Wall St. Rank hold HNI as of Q3 2018.

Aspiriant LLC reported no remaining HNI Corp position as of Q3 2018 after selling out during the quarter.
Aspiriant LLC sold 7,781 HNI Corp shares in Q3 2018, an estimated $289K.
Aspiriant LLC first reported a position in HNI Corp in Q4 2013 and held it in 2 quarters.
Aspiriant LLC's HNI Corp position peaked at $1.58M in Q4 2013.
178 funds tracked by Wall St. Rank held HNI Corp as of Q3 2018.

Based on Aspiriant LLC's 13F filing for Q3 2018, filed 26 Oct 2018.